EcoDrugPlus

Cytochrome P450, Family 3, Subfamily A, Polypeptide 65

Ensembl ID : ENSDARG00000103295
Gene Symbol: CYP3A65
12 Enzyme and pathways 5 Cross references
602 Possible Orthologues:

Cytochrome P450, Family 3, Subfamily C, Polypeptide 4

Ensembl ID : ENSDARG00000070021
Gene Symbol: CYP3C4
7 Enzyme and pathways 5 Cross references
559 Possible Orthologues:

Cytochrome P450, Family 3, Subfamily C, Polypeptide 1

Ensembl ID : ENSDARG00000015575
Gene Symbol: CYP3C1
7 Enzyme and pathways 5 Cross references
555 Possible Orthologues:

Cytochrome P450, Family 3, Subfamily C, Polypeptide 2

Ensembl ID : ENSDARG00000037874
Gene Symbol: CYP3C2
5 Cross references
555 Possible Orthologues:

Cytochrome P450, Family 3, Subfamily C, Polypeptide 3

Ensembl ID : ENSDARG00000037873
Gene Symbol: CYP3C3
5 Cross references
555 Possible Orthologues:

Cytochrome P450, Family 46, Subfamily A, Polypeptide 1, Tandem Duplicate 1

Ensembl ID : ENSDARG00000012137
Gene Symbol: CYP46A1.1
5 Cross references
255 Possible Orthologues:

Cytochrome P450, Family 46, Subfamily A, Polypeptide 1, Tandem Duplicate 2

Ensembl ID : ENSDARG00000004262
Gene Symbol: CYP46A1.2
5 Cross references
255 Possible Orthologues:

Cytochrome P450, Family 46, Subfamily A, Polypeptide 1, Tandem Duplicate 3

Ensembl ID : ENSDARG00000089177
Gene Symbol: CYP46A1.3
5 Cross references
255 Possible Orthologues:

Cytochrome P450, Family 46, Subfamily A, Polypeptide 1, Tandem Duplicate 4

Ensembl ID : ENSDARG00000113820
Gene Symbol: CYP46A1.4
5 Cross references
255 Possible Orthologues:

Diacylglycerol O-Acyltransferase 1a

Ensembl ID : ENSDARG00000103503
Gene Symbol: DGAT1A
5 Cross references
192 Possible Orthologues:

Diacylglycerol O-Acyltransferase 1b

Ensembl ID : ENSDARG00000054914
Gene Symbol: DGAT1B
10 Enzyme and pathways 5 Cross references
188 Possible Orthologues:

Dihydroorotate Dehydrogenase

Ensembl ID : ENSDARG00000051889
Gene Symbol: DHODH
4 Enzyme and pathways 5 Cross references
173 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).